Strikingly, western blot analysis showed that miR-133a-3p overexpression downregulated MYH9 in NPC cells, whereas suppression of miR-133a-3p with an inhibitor notably increased MYH9 expression in NPC cells (Fig. 3b). The gene discussed is MYH9; the disease is nasopharyngeal carcinoma.